The Efficacy and Safety Profiles of Reduced CyBorD with Newly Diagnosed and Refractory/Relapsed Mult

来源 :2016第九届世界癌症大会 | 被引量 : 0次 | 上传用户：lintao31

【摘要】

：

We have studied to efficacy and safety profiles of combined chemotherapy with newly diagnosed and refractory/relapsed multiple myeloma (MM) such as cyclophosphamide (CPA),bortezomib (Bor),and dexameth

【作者】

：

Naoko Handa

【机构】

：

Department of Oncology and Hematology Edogawa Hospital Japan

【出处】

：

2016第九届世界癌症大会

【发表日期】

：

2016年7期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Detection of Cervical (pre)Cancer on the Basis of Cervicovaginal Fluid:Inclusion of Several Biomarke

Infection of the cervix with an oncogenic form of human papillomavirus (mostly HPV 16 and 18) is the most common cause of cervical cancer.Current screening methods for cervical cancer have several dis

会议

Molecular Diagnosis and Personalized Medicine of Colorectal Cancer

Personalized medicine,in concert with targeted oncologic therapy,has become one of the most active,rapidly advancing,and clinically challenging pursuits in cancer treatment.

会议

Plasma Genetic and Genomic Abnormalities Predict Treatment Response and Clinical Outcome in Advanced

Liquid biopsies,examinations of tumor components in body fluids,have shown promise for predicting clinical outcomes.To evaluate tumor-associated genomic and genetic variations in plasma cell-free DNA

会议

eIF3a is Clinically Relevant in Urinary Bladder Cancer Although Independent of Translation Initiatio

Translation initiation is an essential biological process.The eukaryotic translation initiation factor (eIF) 3a,the largest subunit of the eIF3 complex,is an important functional element in ribosome e

会议

Ubiquitin Associated Protein 2 Negatively Regulates the Invasion of Hepatocellular Carcinoma Cell by

The ubiquitin-dependent proteasomal degradation of proteins controls signaling and cellular survival and plays an important role in transcriptional regulation.

会议

Genetic Analysis of Cancer Mutations in the Blood of Cancer Patients

Detection of somatic mutations from the NSCLC tissue has been routinely practiced to identify eligible patients for the targeted drug therapy.

会议

DEAD-box RNA Helicase DP103 as a Biomarker for Therapeutic Response to Docetaxel

Resistance to chemotherapy offers limitations to the treatment of breast cancer.This has generated an increased interest in identifying new biomarkers to better predict drug responses among patients.

会议

Is There a Space for Brachytherapy of Vaginal Intraepithelial Neoplasia? A Single Institution Study

To retrospectively evaluate the efficacy of HDR (High Dose Rate) brachytherapy (BT) of vaginal intraepithelial neoplasia (VAIN) with a special focus on analysis of toxicity.

会议

Efficacy and Safety of Capecitabine and Oxaliplatin (CapOX) as an Adjuvant Therapy in Japanese for S

A number of large-scale clinical trials have demonstrated that using a combination of oxaliplatin and fluoropyrimidines as an adjuvant chemotherapy for stage Ⅱ/Ⅲ colon cancer improved the prognosis.

会议

Co-delivery of Anti-cancer Therapeutics to Treat Cancers Using Nanoparticle Platforms

In this talk,I will present the recent research work in our group on the cancer treatment using nanoparticle platform to co-deliver two anti-cancer therapeutics.

会议

The Efficacy and Safety Profiles of Reduced CyBorD with Newly Diagnosed and Refractory/Relapsed Mult

其他学术论文